Development of a new vesicular formulation for delivery of Ifosfamide: Evidence from in vitro, in vivo, and in silico experiments
Ifosfamide (IFO) is a member of the oxazaphosphorine family of alkylating drugs that exhibits anticancer and immunoregulatory properties. The toxicity of IFO is dose-limited because of its biotransformation into highly reactive metabolites, including acrolein and chloroacetaldehyde. Here, we aimed t...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Arabian Journal of Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1878535223005488 |